Expert Advice 26 Apr 2024 Biotech career: What it’s really like being a research assistant Labiotech spoke to Elina Kuznecova, a research assistant at the University of Oxford, to find out about what the role of a research assistant entails. April 26, 2024 - 6 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 24 Apr 2024 Overcoming toxicities: are IL-2 smart cytokines the next big thing? A more advanced form of IL-2 cytokine therapy called IL-2 smart cytokines could overcome side effects, and shake up cancer care as we know it. April 24, 2024 - 7 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 16 Apr 2024 Seven biotech companies climbing their way up in Colorado We take a look at seven biotechs in Colorado that have secured funding in recent years, to make headway with their pipeline candidates. April 16, 2024 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 15 Apr 2024 Does the FDA need to tighten its grip on drug trials in the U.S.? Studies suggest that the FDA has been less rigorous with its drug approval standards. We looked at the current state of the approval process. April 15, 2024 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 9 Apr 2024 Eight biotech companies you should know about in Austria Here are eight Austrian biotech companies that have received funding in recent years to propel their pioneering innovations forward. April 9, 2024 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 28 Mar 2024 Are these T cell receptor (TCR) therapy companies on your radar? As biotechs step up in the TCR therapy space, here are seven companies with promising candidates in the clinic. March 28, 2024 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 27 Mar 2024 Are new treatments for multiple sclerosis on the horizon? As the wait for new multiple sclerosis treatments continue, here are some ongoing clinical trials that hold promise. March 27, 2024 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 21 Mar 2024 Eight CAR-T cell therapy companies you should know about Discover eight promising biotech companies that are advancing their CAR T cell therapy candidates in the clinic. March 21, 2024 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 20 Mar 2024 Are molecular glues the key to undruggable targets? As more biopharmas get sticky with molecular glue developers and venture capital interest grows, here is a review of the field. March 20, 2024 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 14 Mar 2024 Rett syndrome: advances in gene therapy brings hope Explore the latest advancements in treating Rett syndrome, a rare genetic disorder, including groundbreaking gene therapies and drug trials. March 14, 2024 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 11 Mar 2024 Biotech bankruptcies: what to expect in 2024 following a record year? 2023 broke the record for the highest number of biotech bankruptcies in a decade. Can biotechs mitigate the risk in 2024? March 11, 2024 - 7 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 7 Mar 2024 Can AbbVie’s legacy live beyond its once best-selling drug Humira? The sales of AbbVie’s Humira, once a best-seller, have dropped. Now, with a new CEO announced, things are about to change for the company. March 7, 2024 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email